Clorazepate and congenital malformations.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000015:Abnormalities, Multiple / Q000139:chemically induced; D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D003009:Clorazepate Dipotassium / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium